Mr Andrew Thomas Coyne
Mr Andrew Thomas Coyne was appointed in a total of 7 companies and resigned from 6 of these appointments.
Role
Director
Country Of Residence
United Kingdom
Nationality
British
Date of Birth
May 1951
Occupations
Sales And Marketing • Company Director
Active
0
Resigned
6
Dissolved
1
Other
0
Total
7
Companies
| Company | Timeline | Status | |
Atac Consultants Ltd Director • Sales And Marketing | 16 Oct 2013←2 Years 1 Month→17 Nov 2015 | Dissolved | |
| Doncaster Pharmaceuticals Group Limited Director • Company Director | 21 Aug 1999←5 Months→11 Feb 2000 | Liquidation | |
| Pharmaceutical Identity Limited Director • Director | 2 Aug 1999←6 Months→11 Feb 2000 | Dissolved | |
| B.R. Lewis Pharmaceuticals Limited Director • Company Director | 2 Aug 1999←6 Months→11 Feb 2000 | Dissolved | |
| Value Generics Limited Director • Company Director | 2 Aug 1999←6 Months→11 Feb 2000 | Dissolved | |
| Regentmoor Limited Director • Company Director | 2 Aug 1999←6 Months→11 Feb 2000 | Dissolved | |
| Renfield Limited Director • Company Director | 2 Aug 1999←6 Months→11 Feb 2000 | Dissolved | |
Mutual People
- Mr Richard Emil FreudenbergPharmaceutical Identity Limited, Value Generics Limited, Doncaster Pharmaceuticals Group Limited, and 3 more are mutual companies.
- Mrs Stephanie Joy EllisonDoncaster Pharmaceuticals Group Limited, Renfield Limited, B.R. Lewis Pharmaceuticals Limited, and 3 more are mutual companies.
- Mr Ian Colin BrownleeRegentmoor Limited, B.R. Lewis Pharmaceuticals Limited, Doncaster Pharmaceuticals Group Limited, and 3 more are mutual companies.
- John WhitworthDoncaster Pharmaceuticals Group Limited, Regentmoor Limited, Renfield Limited, and 3 more are mutual companies.
- William John KentRegentmoor Limited, B.R. Lewis Pharmaceuticals Limited, Doncaster Pharmaceuticals Group Limited, and 2 more are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
